{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:49:23Z","timestamp":1778626163919,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.leu.2402545","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T10:59:36Z","timestamp":1035197976000},"page":"1437-1442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes"],"prefix":"10.1038","volume":"16","author":[{"given":"M","family":"Lauten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Beger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,7,31]]},"reference":[{"key":"BF2402545_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia N Engl J Med 1998 339: 605\u2013615","journal-title":"N Engl J Med"},{"key":"BF2402545_CR2","first-page":"139","volume":"30","author":"H Riehm","year":"1987","unstructured":"Riehm H, Feickert HJ, Schrappe M, Henze G, Schellong G . Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis Hamatol Bluttransfus 1987 30: 139\u2013146","journal-title":"Hamatol Bluttransfus"},{"key":"BF2402545_CR3","first-page":"2730","volume":"92","author":"M Schrappe","year":"1998","unstructured":"Schrappe M, Arico M, Harbott J, Biondi A, Zimmermann M, Conter V, Reiter A, Valsecchi MG, Gadner H, Basso G, Bartram CR, Lampert F, Riehm H, Masera G . Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome Blood 1998 92: 2730\u20132741","journal-title":"Blood"},{"key":"BF2402545_CR4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","volume":"94","author":"M Dordelmann","year":"1999","unstructured":"Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M . Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia Blood 1999 94: 1209\u20131217","journal-title":"Blood"},{"key":"BF2402545_CR5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","volume":"14","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, Gadner H, Odenwald E, Riehm H . Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin\u2013Frankfurt\u2013Munster Leukemia 2000 14: 2205\u20132222","journal-title":"Leukemia"},{"key":"BF2402545_CR6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","volume":"86","author":"A Gajjar","year":"1995","unstructured":"Gajjar A, Ribeiro R, Hancock ML, Rivera GK, Mahmoud H, Sandlund JT, Crist WM, Pui CH . Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia Blood 1995 86: 1292\u20131295","journal-title":"Blood"},{"key":"BF2402545_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","volume":"14","author":"PG Steinherz","year":"1996","unstructured":"Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Chappell R, Hammond D, Bleyer WA . Cytoreduction and prognosis in acute lymphoblastic leukemia \u2013 the importance of early marrow response: report from the Childrens Cancer Group J Clin Oncol 1996 14: 389\u2013398","journal-title":"J Clin Oncol"},{"key":"BF2402545_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","volume":"345","author":"JM Chessells","year":"1995","unstructured":"Chessells JM, Bailey C, Richards SM . Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia Lancet 1995 345: 143\u2013148","journal-title":"Lancet"},{"key":"BF2402545_CR9","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1200\/JCO.1997.15.5.1824","volume":"15","author":"A Thyss","year":"1997","unstructured":"Thyss A, Suciu S, Bertrand Y, Mazingue F, Robert A, Vilmer E, Mechinaud F, Benoit Y, Brock P, Ferster A, Lutz P, Boutard P, Marguerite G, Plouvier E, Michel G, Plantaz D, Munzer M, Rialland X, Chantraine JM, Norton L, Solbu G, Philippe N, Otten J . Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group J Clin Oncol 1997 15: 1824\u20131830","journal-title":"J Clin Oncol"},{"key":"BF2402545_CR10","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1996.14.8.2403","volume":"14","author":"M Schrappe","year":"1996","unstructured":"Schrappe M, Reiter A, Riehm H . Cytoreduction and prognosis in childhood acute lymphoblastic leukemia J Clin Oncol 1996 14: 2403\u20132406","journal-title":"J Clin Oncol"},{"key":"BF2402545_CR11","first-page":"3310","volume":"95","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H . Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German\u2013Austrian\u2013Swiss ALL-BFM Study Group Blood 2000 95: 3310\u20133322","journal-title":"Blood"},{"key":"BF2402545_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0145-2126(83)90053-X","volume":"7","author":"CH Pui","year":"1983","unstructured":"Pui CH, Costlow ME, Kalwinsky DK, Dahl GV . Glucocorticoid receptors in childhood acute non-lymphocytic leukemia Leuk Res 1983 7: 11\u201316","journal-title":"Leuk Res"},{"key":"BF2402545_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1067\/mai.2000.106486","volume":"105","author":"AR Sousa","year":"2000","unstructured":"Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH . Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform J Allergy Clin Immunol 2000 105: 943\u2013950","journal-title":"J Allergy Clin Immunol"},{"key":"BF2402545_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1006\/bbrc.1998.9980","volume":"254","author":"H Shahidi","year":"1999","unstructured":"Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA, Chrousos GP, Daughaday WH, Gregory SA, Plate JM . Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia Biochem Biophys Res Commun 1999 254: 559\u2013565","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2402545_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s004390050425","volume":"99","author":"JW Koper","year":"1997","unstructured":"Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA, Grobbee DE, Karl M, de Jong FH, Brinkmann AO, Lamberts SW . Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance Hum Genet 1997 99: 663\u2013668","journal-title":"Hum Genet"},{"key":"BF2402545_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/00008571-200011000-00006","volume":"10","author":"G Anderer","year":"2000","unstructured":"Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K, Stanulla M . Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia Pharmacogenetics 2000 10: 715\u2013726","journal-title":"Pharmacogenetics"},{"key":"BF2402545_CR17","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1074\/jbc.272.20.13047","volume":"272","author":"KD Dittmar","year":"1997","unstructured":"Dittmar KD, Pratt WB . Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90.p60.hsp70-dependent step is sufficient for creating the steroid binding conformation J Biol Chem 1997 272: 13047\u201313054","journal-title":"J Biol Chem"},{"key":"BF2402545_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","volume":"334","author":"F Bazzoni","year":"1996","unstructured":"Bazzoni F, Beutler B . The tumor necrosis factor ligand and receptor families N Engl J Med 1996 334: 1717\u20131725","journal-title":"N Engl J Med"},{"key":"BF2402545_CR19","first-page":"83","volume":"6","author":"K Warzocha","year":"1995","unstructured":"Warzocha K, Bienvenu J, Coiffier B, Salles G . Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system Eur Cytokine Netw 1995 6: 83\u201396","journal-title":"Eur Cytokine Netw"},{"key":"BF2402545_CR20","first-page":"2834","volume":"84","author":"D Franchimont","year":"1999","unstructured":"Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V . Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor J Clin Endocrinol Metab 1999 84: 2834\u20132839","journal-title":"J Clin Endocrinol Metab"},{"key":"BF2402545_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","volume":"1","author":"AG Wilson","year":"1992","unstructured":"Wilson AG, di Giovine FS, Blakemore AI, Duff GW . Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product Hum Mol Genet 1992 1: 353","journal-title":"Hum Mol Genet"},{"key":"BF2402545_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jlb.66.4.562","volume":"66","author":"LJ Abraham","year":"1999","unstructured":"Abraham LJ, Kroeger KM . Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease J Leukoc Biol 1999 66: 562\u2013566","journal-title":"J Leukoc Biol"},{"key":"BF2402545_CR23","first-page":"1","volume":"45","author":"AG Wilson","year":"1995","unstructured":"Wilson AG, di Giovine FS, Duff GW . Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases J Inflamm 1995 45: 1\u201312","journal-title":"J Inflamm"},{"key":"BF2402545_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/infdis\/174.4.878","volume":"174","author":"S Nadel","year":"1996","unstructured":"Nadel S, Newport MJ, Booy R, Levin M . Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease J Infect Dis 1996 174: 878\u2013880","journal-title":"J Infect Dis"},{"key":"BF2402545_CR25","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/bjc.1998.391","volume":"77","author":"K Warzocha","year":"1998","unstructured":"Warzocha K, Bienvenu J, Ribeiro P, Moullet I, Dumontet C, Neidhardt-Berard EM, Coiffier B, Salles G . Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients Br J Cancer 1998 77: 2357\u20132362","journal-title":"Br J Cancer"},{"key":"BF2402545_CR26","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","volume":"91","author":"K Warzocha","year":"1998","unstructured":"Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G . Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 1998 91: 3574\u20133581","journal-title":"Blood"},{"key":"BF2402545_CR27","first-page":"2451","volume":"3","author":"C Dosquet","year":"1997","unstructured":"Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F . Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res 1997 3: 2451\u20132458","journal-title":"Clin Cancer Res"},{"key":"BF2402545_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2141.1997.9912636.x","volume":"97","author":"J Demeter","year":"1997","unstructured":"Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmid M, Messer G . Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia Br J Haematol 1997 97: 107\u2013112","journal-title":"Br J Haematol"},{"key":"BF2402545_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1523-1755.1999.00536.x","volume":"56","author":"D Sankaran","year":"1999","unstructured":"Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV . Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int 1999 56: 281\u2013288","journal-title":"Kidney Int"},{"key":"BF2402545_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s002620050483","volume":"46","author":"VP Khatri","year":"1998","unstructured":"Khatri VP, Caligiuri MA . A review of the association between interleukin-10 and human B-cell malignancies Cancer Immunol Immunother 1998 46: 239\u2013244","journal-title":"Cancer Immunol Immunother"},{"key":"BF2402545_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10428199909083381","volume":"34","author":"B Klein","year":"1999","unstructured":"Klein B, Lu ZY, Gu ZJ, Costes V, Jourdan M, Rossi JF . Interleukin-10 and Gp130 cytokines in human multiple myeloma Leuk Lymphoma 1999 34: 63\u201370","journal-title":"Leuk Lymphoma"},{"key":"BF2402545_CR32","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V92.10.3943","volume":"92","author":"PG Middleton","year":"1998","unstructured":"Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM . Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants Blood 1998 92: 3943\u20133948","journal-title":"Blood"},{"key":"BF2402545_CR33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.510300207","volume":"30","author":"CJ Edwards-Smith","year":"1999","unstructured":"Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE . Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa Hepatology 1999 30: 526\u2013530","journal-title":"Hepatology"},{"key":"BF2402545_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0165-5728(98)00228-8","volume":"94","author":"DR Huang","year":"1999","unstructured":"Huang DR, Zhou YH, Xia SQ, Liu L, Pirskanen R, Lefvert AK . Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease J Neuroimmunol 1999 94: 82\u201387","journal-title":"J Neuroimmunol"},{"key":"BF2402545_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1034\/j.1399-0039.1999.540408.x","volume":"54","author":"A Tagore","year":"1999","unstructured":"Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, Sinnott PJ, Hutchinson IV . Interleukin-10 (IL-10) genotypes in inflammatory bowel disease Tissue Antigens 1999 54: 386\u2013390","journal-title":"Tissue Antigens"},{"key":"BF2402545_CR36","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y","volume":"42","author":"E Crawley","year":"1999","unstructured":"Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P . Polymorphic haplotypes of the interleukin-10 5\u2032 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 1999 42: 1101\u20131108","journal-title":"Arthritis Rheum"},{"key":"BF2402545_CR37","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/S0140-6736(05)70489-X","volume":"352","author":"J Eskdale","year":"1998","unstructured":"Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M, Gallagher G . Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility Lancet 1998 352: 1282\u20131283","journal-title":"Lancet"},{"key":"BF2402545_CR38","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/rheumatology\/37.9.988","volume":"37","author":"G Coakley","year":"1998","unstructured":"Coakley G, Mok CC, Hajeer AH, Ollier WE, Turner D, Sinnott PJ, Hutchinson IV, Panayi GS, Lanchbury JS . Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome Br J Rheumatol 1998 37: 988\u2013991","journal-title":"Br J Rheumatol"},{"key":"BF2402545_CR39","first-page":"2314","volume":"24","author":"M Lazarus","year":"1997","unstructured":"Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV . Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus J Rheumatol 1997 24: 2314\u20132317","journal-title":"J Rheumatol"},{"key":"BF2402545_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.V97.1.256","volume":"97","author":"L Fayad","year":"2001","unstructured":"Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R . Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome Blood 2001 97: 256\u2013263","journal-title":"Blood"},{"key":"BF2402545_CR41","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1164\/ajrccm.156.4.12tac-14","volume":"156","author":"LJ Rosenwasser","year":"1997","unstructured":"Rosenwasser LJ, Borish L . Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10) Am J Respir Crit Care Med 1997 156: S152\u2013155","journal-title":"Am J Respir Crit Care Med"},{"key":"BF2402545_CR42","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1164\/ajrccm.158.6.9804011","volume":"158","author":"K Hobbs","year":"1998","unstructured":"Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L . Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma Am J Respir Crit Care Med 1998 158: 1958\u20131962","journal-title":"Am J Respir Crit Care Med"},{"key":"BF2402545_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3109\/07853899809002488","volume":"30","author":"M Hurme","year":"1998","unstructured":"Hurme M, Lahdenpohja N, Santtila S . Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases Ann Med 1998 30: 469\u2013473","journal-title":"Ann Med"},{"key":"BF2402545_CR44","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00007890-199709150-00021","volume":"64","author":"D Turner","year":"1997","unstructured":"Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV . Cytokine gene polymorphism and heart transplant rejection Transplantation 1997 64: 776\u2013779","journal-title":"Transplantation"},{"key":"BF2402545_CR45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/00007890-200004150-00054","volume":"69","author":"AJ Bathgate","year":"2000","unstructured":"Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV . The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection Transplantation 2000 69: 1514\u20131517","journal-title":"Transplantation"},{"key":"BF2402545_CR46","first-page":"2","volume":"1","author":"M Stanulla","year":"2001","unstructured":"Stanulla M, Schrauder A, Welte K, Schrappe M . Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy BMC Blood Disorders 2001 1: 2","journal-title":"BMC Blood Disorders"},{"key":"BF2402545_CR47","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122\u20133133","journal-title":"Blood"},{"key":"BF2402545_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s002510050250","volume":"46","author":"J Eskdale","year":"1997","unstructured":"Eskdale J, Kube D, Tesch H, Gallagher G . Mapping of the human IL10 gene and further characterization of the 5\u2032 flanking sequence Immunogenetics 1997 46: 120\u2013128","journal-title":"Immunogenetics"},{"key":"BF2402545_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV . An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 1997 24: 1\u20138","journal-title":"Eur J Immunogenet"},{"key":"BF2402545_CR50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0168-8278(00)80091-4","volume":"32","author":"PT Donaldson","year":"2000","unstructured":"Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R . The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility\/resistance J Hepatol 2000 32: 882\u2013886","journal-title":"J Hepatol"},{"key":"BF2402545_CR51","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V94.11.3941","volume":"94","author":"J Cavet","year":"1999","unstructured":"Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM . Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants Blood 1999 94: 3941\u20133946","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402545","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:36:19Z","timestamp":1648762579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,31]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF2402545"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402545","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,31]]},"assertion":[{"value":"1 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}